55 - What are cGCPs? Foundations and Ethical Principles (S22E1)
From Concept to Medicine - A Comprehensive Drug Development Journey
This episode defines current Good Clinical Practices (cGCPs) and explores their pivotal role in safeguarding trial participants and ensuring the integrity of data. It delves into the ethical considerations inherent in clinical research, emphasizing the significance of informed consent as a cornerstone of ethical practice. The discussion also highlights the critical importance of meticulous protocol design in establishing a solid foundation for robust clinical research. Furthermore, the episode navigates through the key concepts and aims to simplify the understanding of CGCPs for a broader audience.
The episode then goes on to examine excerpts from the Code of Federal Regulations (CFR), particularly for those less familiar with this resource, which serves as the rule book for the federal government. It addresses how rules and regulations cover diverse topics, including electronic records management and the standards applied in manufacturing and clinical trials. This is rounded out by books on Good Manufacturing Practices and the important quality systems that are also in play. Finally, the episode closes by exploring the ICH guidelines as an international consideration in the harmonization of drug development.
Available Results
Generated results are saved to the knowledge database for reuse and search.
Extract Knowledge
Pick what you want extracted first. Model, scope, and chapter options appear after a template is selected.
Transcript
Okay, so we all want to feel confident, you know, in the medications that we use, that they're safe. Absolutely. And that they're really truly effective. Right. But have you ever really stopped to think about, like, all of the work that goes on behind the scenes to make that possible? Yeah. To be able to trust those medications? A hundred percent. Like all of the systems and the regulations? Yeah. And one of the most important sets of those standards is current good clinical practices. Yeah, we call those CGCPs for short. Or CGCPs. You'll hear us say that a lot. Yeah, you'll hear us say that a lot. So we're taking a deep dive into that. Yeah, it's a big one. Into that world today. Absolutely. So this is really not just about like... dry rules, regulations. This is really about the foundation of how we actually conduct clinical trials and how we test these new treatments. So we're going to unpack these core principles of CGCPs and we'll highlight their really vital role in protecting the people who volunteer to participate in research. And also at the same time, making sure that the data we get from those trials is reliable and robust. And to do that, We've got kind of a wealth of information in front of us here. We do. We're looking at a transcript that's specifically dedicated to the foundations and the ethical principles of CGCPs. Very important. We've also got excerpts from the Code of Federal Regulations. That's the CFR. And for those of you who are unfamiliar with the CFR, that's basically like... the rule book of the federal government. For the US government. From the US government. That's right. It's where all the rules and regulations are published. Exactly. And these cover everything from how you manage electronic records to the standards that we use for manufacturing. Yes. And actually conducting clinical trials. It's all in there. It's all in there. Yeah. And we've also got some things from like... books on GMP, good manufacturing practices. Very important. Quality systems. Yeah. We've got the ICH guidelines. The internationalists. The international guidelines. Yeah, so these are guidelines that countries around the world use to harmonize drug development. It's really important for global trade and safety. Yeah, and then we've got... transcripts from YouTube videos that kind of break down GMP clinical trials, FDA regulations. Nice, so we can get the perspective of people explaining these things. Exactly. That's really helpful. And then we've even got a report that analyzes findings from FDA inspections. That's a good one. Which are known as Form 483 observations. Yeah, those are the things that the FDA finds when they do an inspection. And if you have 483 observations, That means you're in trouble. You're in trouble, potentially. So we're going to look at all those to understand CGCPs better. Yeah. So our mission here is pretty straightforward. Yeah, what is it? We want to give you a clear understanding of what CGCPs are all about. Yep. We're going to explain why they're so important. To everybody. Yeah, to everybody. And explore these really fundamental ethical and procedural elements that make them up. the core of it. Yeah, so let's just start with the basics. What are CGCPs? So basically, CGCPs are these internationally recognized standards. They're ethical and scientific quality standards that govern how clinical trials are designed, how they're conducted, how they're recorded, and how they're reported. Okay, so it's like... It's the whole thing. It's like the rule book. It is the rule book. For running a clinical trial. It's the rule book for anyone involved in testing new medical treatments in humans. Okay. That's what it is. So it's not just like a good idea. No. It's the standard. It's the standard. That everyone's expected to follow. Exactly. Okay, so why do we have this? Good question. Like what's the purpose? So CGCPs serve to really critical purposes. First and foremost, they're there to protect people, the people who participate in the trials, their safety, their well -being, and their rights. That's the main ethical commitment. But equally important is the role that they play in ensuring the quality of the data that comes out of the trials. Because if we can't trust the data, we can't trust any of the conclusions that are made. about whether a treatment's safe and effective. That makes sense. Right. So it's all about protecting the participants and making sure that the science is sound and trustworthy. Yeah. OK, so we've talked about the GMP regulations before. Yes, we have. And I feel like that's probably a good place to start. That's a good connection. With kind of putting this into a bigger picture. How did we get here? So GMPs are all about the quality of drug manufacturing, making sure that the drugs are made correctly. But CGCPs are about making sure that the drugs are actually safe and effective and that we're testing them in the right way. So the history of GMPs can really help us understand how we got to this point where we care so much about ethics and research. So we've talked about the thalidomide disaster. back in the 1960s, where this drug was given to pregnant women. And it caused really severe birth defects in their children. Yeah, it was really tragic. It was a huge tragedy. And it really highlighted that just making sure that the medicines were manufactured correctly wasn't enough. We needed to actually make sure that they were safe and effective. Before you give them to people. Exactly, before you give them to people. Especially vulnerable populations like pregnant women. So this tragedy was a major driving force behind developing stricter regulations that focused on patient safety and data integrity. So GMP ensures that medicine is well made. Right. CGCP ensures that we prove it actually works. In humans. In humans. Yeah. And that it's safe. Ethically and scientifically. OK. So that's a really good distinction. Yeah, it's a big one. And it's a good reminder that these aren't just You know, bureaucratic hoops to jump through. These regulations exist for a reason. They exist because of very real and serious consequences that have happened in the past when we haven't had these regulations in place. Yeah, and when we haven't followed them. Exactly. So it's not just a checklist. No, not a checklist. No, it's more than that. It's more about like a commitment to quality and ethics. It's a commitment to... building quality and ethical considerations into every single stage of the research process. Yeah, that's throughout the entire process. From the beginning, from the design of the study all the way through to the reporting of the results. Yeah, okay, so then What are the core ethical principles that underpin CGCPs? So there are a few really key ethical principles that guide all clinical research. And these are things like respect for persons, beneficence, and justice. OK, so let's talk about those. Let's bring those down. A little more. What does respect for persons actually mean? So respect for persons means that we recognize the autonomy of individuals and their right to make their own decisions about whether or not they want to participate in research and we also have to protect those. who have diminished autonomy. Okay, so like people who can't. Yeah, like children. Yeah. Or people with cognitive impairments. Right. They might not be able to make those decisions for themselves. You have to protect them. Okay. And this principle is really embodied in the idea of informed consent. Informed consent. That's a big one. Yeah, it's a term we hear all the time. It is. When we're talking about it. All the time. Medical research. So what is that? Why is that so important? Informed consent is basically the process of giving potential participants, all of the essential information about a clinical trial. So this includes things like what's the purpose of the trial? What are the procedures involved? What are the potential risks and benefits? And what other treatments might be available? And this information has to be presented in a way. that the potential participant can understand. So it has to be in their language. It has to be at their level of understanding. And their decision to participate has to be completely voluntary. They have to be told that they can withdraw from the study at any time without penalty. So it's not just a one -time signature on a form. It's an ongoing process. It's ongoing. And that's really important. So it's about really making sure that people can make informed decisions about their health. It is about empowering individuals to make choices about their own health and whether or not they want to be part of research. Okay, so we've talked about the participants. What about the actual design of the study? Yeah, that's a good point. How does that impact the ethical conduct and the quality of the data? A well -designed protocol is super important, not just for the ethics, but also for the data. So, if the protocol is not well -designed, it can expose participants to unnecessary risks. And even if it doesn't harm them, it can lead to data that's unreliable. Right, or unusable. Exactly. So then what makes a protocol well designed? Well, there are a few key elements that are really important. So first, you need to have clearly defined objectives and research questions. Like, what are we trying to learn? From this study, you need to know that upfront. Then you need to have criteria for who can participate in the study. These are called inclusion and exclusion criteria. And these criteria have to be scientifically sound, but they also have to be fair. We need to make sure that the burdens and benefits of research are distributed equitably. across different populations. So that's the ethical principle of justice. Making sure that everyone has a fair chance to participate. And then the protocol needs to provide a very detailed description of all the study procedures. So that's things like, what are the interventions? What are the doses? What's the schedule of visits and treatments? What assessments are we doing? All of that stuff. needs to be laid out in detail. And then it needs to include a plan for safety monitoring. How are we going to identify adverse events? How are we going to document them? How are we going to report them? And then finally, you need to have a plan for the statistics. How big is the sample size going to be? How are we going to analyze the data? All of that. So you need to consider all that before you even start the trial. Exactly. And if there are flaws, In the protocol. Yeah, like if the safety monitoring is not adequate. Yeah, or if there aren't enough participants Yeah, then it raises ethical concerns right because you might be putting people at risk, right? But it also undermines the science. Yeah, because the data might not be reliable Okay, so it's both ethical and scientific. It's both. Yeah, it's all connected. Well, okay So let's move on to the data itself. Okay How do CGCPs make sure that the data that we collect during a trial is high quality. Right. So CGCPs really emphasize the importance of data quality and data integrity throughout the whole clinical trial. So every aspect of how you handle that data from the very beginning, when you collect it, to how you analyze it and how you store it. Has to be done with a lot of attention to detail right to make sure the findings are trustworthy Okay, so it's more involved than just like wait more writing some numbers down Yeah, it's not just about recording numbers on a piece of paper or in a spreadsheet No, it's about making sure that the data is accurate. Yeah, and that it's reliable Okay, and one of the key things is documentation, right? So we've talked about good documentation practices before GDP. Yes. Yeah, right and those principles apply here as well. Okay So all records have to be legible. Okay. They have to be contemporaneous. Yeah. Meaning you have to write them down. Yeah. At the time that the event happens. Right. They have to be accurate. Yeah. They have to be original and they have to be attributable. Meaning you know who did it. Exactly. Okay. And what about all the electronic data? Oh yeah. That's a big one these days. Yeah because I mean that's. Most data is electronic. Most data is electronic now. Yeah. So how do CGCPs address that. So the CFR has a whole section on electronic records and electronic signatures. It's 21 CFR part 11. And these regulations are there to make sure that the data is authentic, that it's reliable, that it's confidential. So you have to have things like unique electronic signatures, audit trails, so you can track any changes to the records, and you have to validate the computer systems to make sure that they're working properly. So it's a whole other layer of complexity. But the underlying principles are the same. Accuracy, reliability, trustworthiness. That's the key. What about lab testing? Oh, yeah. That's a big one. Yeah, because that's where we're getting a lot of the data about how the drug is working in the body. So the integrity of lab testing is super important because it provides key data that supports the safety and efficacy of the investigational product. So here's where GMP comes in again. Even though GMP is focused on manufacturing, a lot of those principles apply to lab testing as well. So things like having controlled processes and robust quality systems. and using risk management. All of those things underpin the quality of the lab work. OK, and then specifically, what kinds of things are we looking for? So you need to have really good quality control procedures in the lab. So that means things like using check standards to make sure that your instruments are calibrated correctly, running blank samples, to make sure there's no contamination, establishing detection and quantitation limits so you know how much of the drug you can actually detect. and then having data review processes where multiple people look at the data to make sure it's accurate. So it's all about making sure that the lab testing is reliable and accurate. So it's a very interconnected system where all these different regulations and guidelines are working together. To ensure quality. But every step. All of this stuff, it's not just a Good idea. Right. It's a requirement. It is a regulatory requirement. Right. So if you're doing... It's a law. Yeah. If you're doing a clinical trial... Yeah. You have to follow these rules. You have to follow the rules. Right. If you want your data to be accepted... Right. By the FDA. By the regulatory authorities? Exactly. Yeah. Okay. So it's not something to mess around with. Right. You know. And what happens if you don't? Bad things. Yeah. What are the consequences? So the FDA does inspections... Right. to check up on people and make sure they're following the rules. And if they find that you're not, there could be some pretty serious consequences. Like what? Well, they can shut down your trial. Oh, wow. They could reject your data. Yeah. They could delay your drug approval. Yeah. And they could even take other regulatory actions. Like fines. Yeah, fines, warning letters, all sorts of stuff. OK. So it's not something you want to mess with. It's not something to take lightly. No. Yeah. So understanding CGCPs really gives you a good look into how medicines are developed. Exactly. And all the work and the ethical considerations. Yeah, that's a lot of work. that go into that. And it's all for good reason. Yeah. Right. So whether you're like preparing for a meeting or just trying to get up to speed. Or just curious. In a certain area or just curious how it all works. Right. Knowing these principles really helps you appreciate how complex it all is. It's very complex. Yeah. And all the safeguards that are in place. To protect everybody. All about protecting people. Yeah. OK. So. Just to recap, CGCPs are a set of international regulations based on ethical principles and they emphasize protecting the participants in clinical trials and ensuring the quality and the integrity of the data that's collected. It's all about the data. This is achieved through a lot of hard work. Yeah. Designing the study protocol. Yes. Very carefully and ethically. It's sticking to the standards. And then following the standards throughout the whole process. From beginning to end. Yeah. It's a long process. OK. So basically, every medical breakthrough that we've ever seen has been built on this foundation. It all relies on CGCPs. Of CGCPs. Yeah. It's the framework for advancing health care responsibly. Wow. Yeah. So if you're interested in learning more about CGCPs, there is a lot of information out there. And I would encourage you to look into the CFR and the ICH guidelines. Those are great resources. Yeah, there's a lot of detail there. There is. And it can be a little bit overwhelming. But it's worth it. What it's worth it. If you want to really understand this stuff. If you really want to understand it. Yeah. Okay. Well, thank you for joining us. Thank you for having me. On this deep dive. It's been a pleasure. Into CGCP. I hope you learned something.